Target intelligence / Profile preview

Astrocyte Metabolic Reprogramming

Molecular classification
Cellular Process, Metabolic Pathway
01

Overview

Astrocytes are glial cells in the CNS that maintain brain metabolic homeostasis. Their metabolism is highly adaptable through a process called metabolic reprogramming, enabling them to support neuronal function, modulate immune responses, and contribute to neuroprotection and tissue repair. Key features include glucose uptake via GLUTs, lactate production via LDH and export via MCTs (astrocyte-neuron lactate shuttle), the pentose phosphate pathway (PPP) for NADPH production, and fatty acid/amino acid metabolism. Reprogramming is triggered by ischemia/hypoxia (increased glucose uptake, glycolysis, lactate output, PPP activity) and neurodegenerative diseases (shift toward aerobic glycolysis). Dysregulation contributes to disease progression via impaired energy supply, altered redox balance, and changes in metabolite shuttling.

Other names
Astrocyte MetabolismAstrocyte Metabolic AdaptationGlia Metabolic ReprogrammingBrain Metabolic Homeostasis (Astrocytes)Astrocyte energy metabolism
02

Biological functions

Energy ProductionMetabolic RegulationNeuroprotectionAntioxidant DefenseGlutamate RecyclingSynaptic Plasticity SupportNeurotransmitter CyclingLactate ShuttleGlycogen metabolism
03

Disease associations

Ischemic StrokeNeurodegenerative Diseases (Alzheimer's, Parkinson's)Traumatic Brain InjuryNeuroinflammationEpilepsyCNS disorders
04

Safety considerations

Dysregulation of astrocyte metabolism can exacerbate neuronal damageShift to aerobic glycolysis can lead to lactate accumulation and acidosisImpaired energy supply during stroke contributes to neuronal injuryAltered redox balance affects susceptibility/resilience against oxidative stressChanges in metabolite shuttling impact cognitive functionsPotential for maladaptive reprogramming in chronic neurodegenerative conditions
05

Biomarkers

Lactate Levels (CSF, Blood)Glutamate Levels (CSF, Synaptic Cleft)Glycogen levelsExpression of GLUT1, LDH5, MCTsNADPH levels

Beyond the preview

Go deeper on Astrocyte Metabolic Reprogramming.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astrocyte Metabolic Reprogramming.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call